Theralase Technologies Inc. (TLTFF)
USD 0.15
(4.23%)
USD 0.15
(4.23%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 658.18 Thousand CAD | 35.56% |
| 2022 | 485.53 Thousand CAD | -14.24% |
| 2021 | 566.18 Thousand CAD | 25.2% |
| 2020 | 452.23 Thousand CAD | -37.41% |
| 2019 | 722.55 Thousand CAD | -16.4% |
| 2018 | 864.26 Thousand CAD | -17.41% |
| 2017 | 1.04 Million CAD | -13.93% |
| 2016 | 1.21 Million CAD | 33.09% |
| 2015 | 913.51 Thousand CAD | 209.02% |
| 2014 | 295.62 Thousand CAD | 55.27% |
| 2013 | 190.39 Thousand CAD | -11.9% |
| 2012 | 216.1 Thousand CAD | -38.16% |
| 2011 | 349.43 Thousand CAD | 7.45% |
| 2010 | 325.21 Thousand CAD | 62.27% |
| 2009 | 200.41 Thousand CAD | -27.08% |
| 2008 | 274.83 Thousand CAD | 24.85% |
| 2007 | 220.13 Thousand CAD | 19.62% |
| 2006 | 184.02 Thousand CAD | 9.84% |
| 2005 | 167.53 Thousand CAD | 41.57% |
| 2004 | 118.34 Thousand CAD | 23.8% |
| 2003 | 95.58 Thousand CAD | 0.0% |
| 2002 | - CAD | 0.0% |
| 2001 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 651.34 Thousand CAD | 4.59% |
| 2024 Q1 | 622.73 Thousand CAD | -5.39% |
| 2023 Q4 | 658.18 Thousand CAD | 22.82% |
| 2023 FY | 658.18 Thousand CAD | 35.56% |
| 2023 Q2 | 573.11 Thousand CAD | 0.1% |
| 2023 Q3 | 535.89 Thousand CAD | -6.49% |
| 2023 Q1 | 572.55 Thousand CAD | 17.92% |
| 2022 FY | 485.53 Thousand CAD | -14.24% |
| 2022 Q4 | 485.53 Thousand CAD | 14.3% |
| 2022 Q3 | 424.79 Thousand CAD | -9.91% |
| 2022 Q1 | 536.59 Thousand CAD | -5.23% |
| 2022 Q2 | 471.53 Thousand CAD | -12.13% |
| 2021 Q4 | 566.18 Thousand CAD | -14.19% |
| 2021 FY | 566.18 Thousand CAD | 25.2% |
| 2021 Q1 | 574.38 Thousand CAD | 27.01% |
| 2021 Q2 | 625.48 Thousand CAD | 8.9% |
| 2021 Q3 | 659.79 Thousand CAD | 5.48% |
| 2020 Q1 | 741.65 Thousand CAD | 2.64% |
| 2020 Q2 | 553.68 Thousand CAD | -25.35% |
| 2020 FY | 452.23 Thousand CAD | -37.41% |
| 2020 Q4 | 452.23 Thousand CAD | -6.16% |
| 2020 Q3 | 481.94 Thousand CAD | -12.96% |
| 2019 Q2 | 936.98 Thousand CAD | 7.88% |
| 2019 Q3 | 913.25 Thousand CAD | -2.53% |
| 2019 Q1 | 868.57 Thousand CAD | 0.5% |
| 2019 Q4 | 722.55 Thousand CAD | -20.88% |
| 2019 FY | 722.55 Thousand CAD | -16.4% |
| 2018 Q2 | 896.3 Thousand CAD | -5.6% |
| 2018 FY | 864.26 Thousand CAD | -17.41% |
| 2018 Q4 | 864.26 Thousand CAD | -1.91% |
| 2018 Q1 | 949.46 Thousand CAD | -9.27% |
| 2018 Q3 | 881.12 Thousand CAD | -1.69% |
| 2017 Q2 | 1.16 Million CAD | 0.52% |
| 2017 FY | 1.04 Million CAD | -13.93% |
| 2017 Q4 | 1.04 Million CAD | -12.54% |
| 2017 Q3 | 1.19 Million CAD | 2.3% |
| 2017 Q1 | 1.16 Million CAD | -4.29% |
| 2016 Q3 | 1.22 Million CAD | 3.87% |
| 2016 Q2 | 1.17 Million CAD | 9.45% |
| 2016 Q1 | 1.07 Million CAD | 17.53% |
| 2016 Q4 | 1.21 Million CAD | -0.4% |
| 2016 FY | 1.21 Million CAD | 33.09% |
| 2015 FY | 913.51 Thousand CAD | 209.02% |
| 2015 Q4 | 913.51 Thousand CAD | 25.4% |
| 2015 Q3 | 728.45 Thousand CAD | 58.65% |
| 2015 Q1 | 357.4 Thousand CAD | 20.9% |
| 2015 Q2 | 459.16 Thousand CAD | 28.47% |
| 2014 FY | 295.62 Thousand CAD | 55.27% |
| 2014 Q4 | 295.62 Thousand CAD | 16.32% |
| 2014 Q3 | 254.13 Thousand CAD | 16.49% |
| 2014 Q2 | 218.16 Thousand CAD | 13.11% |
| 2014 Q1 | 192.87 Thousand CAD | 1.3% |
| 2013 FY | 190.39 Thousand CAD | -11.9% |
| 2013 Q4 | 190.39 Thousand CAD | -4.78% |
| 2013 Q2 | 200.06 Thousand CAD | 0.22% |
| 2013 Q1 | 199.63 Thousand CAD | -7.62% |
| 2013 Q3 | 199.96 Thousand CAD | -0.05% |
| 2012 Q2 | 257.82 Thousand CAD | -5.27% |
| 2012 Q1 | 272.15 Thousand CAD | -22.12% |
| 2012 FY | 216.1 Thousand CAD | -38.16% |
| 2012 Q3 | 229.97 Thousand CAD | -10.8% |
| 2012 Q4 | 216.1 Thousand CAD | -6.03% |
| 2011 FY | 349.43 Thousand CAD | 7.45% |
| 2011 Q1 | 361.02 Thousand CAD | 11.01% |
| 2011 Q2 | 290.09 Thousand CAD | -19.65% |
| 2011 Q4 | 349.43 Thousand CAD | 21.96% |
| 2011 Q3 | 286.52 Thousand CAD | -1.23% |
| 2010 Q2 | 182.93 Thousand CAD | -10.19% |
| 2010 FY | 325.21 Thousand CAD | 62.27% |
| 2010 Q4 | 325.21 Thousand CAD | 14.29% |
| 2010 Q1 | 203.68 Thousand CAD | 1.63% |
| 2010 Q3 | 284.55 Thousand CAD | 55.55% |
| 2009 FY | 200.41 Thousand CAD | -27.08% |
| 2009 Q1 | 268.72 Thousand CAD | -2.22% |
| 2009 Q2 | 204.17 Thousand CAD | -24.02% |
| 2009 Q3 | 218.81 Thousand CAD | 7.17% |
| 2009 Q4 | 200.41 Thousand CAD | -8.41% |
| 2008 Q1 | 221.63 Thousand CAD | 0.68% |
| 2008 FY | 274.83 Thousand CAD | 24.85% |
| 2008 Q4 | 274.83 Thousand CAD | 3.99% |
| 2008 Q3 | 264.29 Thousand CAD | 33.23% |
| 2008 Q2 | 198.38 Thousand CAD | -10.49% |
| 2007 Q1 | 226.98 Thousand CAD | 23.34% |
| 2007 Q2 | 238.71 Thousand CAD | 5.17% |
| 2007 Q4 | 220.13 Thousand CAD | -10.86% |
| 2007 Q3 | 246.95 Thousand CAD | 3.45% |
| 2007 FY | 220.13 Thousand CAD | 19.62% |
| 2006 Q4 | 184.02 Thousand CAD | -8.72% |
| 2006 Q1 | 182.75 Thousand CAD | 9.08% |
| 2006 Q2 | 175.74 Thousand CAD | -3.83% |
| 2006 FY | 184.02 Thousand CAD | 9.84% |
| 2006 Q3 | 201.59 Thousand CAD | 14.71% |
| 2005 FY | 167.53 Thousand CAD | 41.57% |
| 2005 Q1 | 110.73 Thousand CAD | -6.43% |
| 2005 Q2 | 119.16 Thousand CAD | 7.62% |
| 2005 Q3 | 159.09 Thousand CAD | 33.51% |
| 2005 Q4 | 167.53 Thousand CAD | 5.3% |
| 2004 Q4 | 118.34 Thousand CAD | 47.61% |
| 2004 Q3 | 80.17 Thousand CAD | -19.97% |
| 2004 Q1 | 91.11 Thousand CAD | -4.68% |
| 2004 FY | 118.34 Thousand CAD | 23.8% |
| 2004 Q2 | 100.17 Thousand CAD | 9.94% |
| 2003 Q3 | - CAD | 0.0% |
| 2003 Q4 | 95.58 Thousand CAD | 0.0% |
| 2003 Q2 | - CAD | 0.0% |
| 2003 Q1 | - CAD | 0.0% |
| 2003 FY | 95.58 Thousand CAD | 0.0% |
| 2002 Q4 | - CAD | 0.0% |
| 2002 FY | - CAD | 0.0% |
| 2002 Q1 | - CAD | 0.0% |
| 2002 Q2 | - CAD | 0.0% |
| 2002 Q3 | - CAD | 0.0% |
| 2001 FY | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| IR-Med Inc. | -81.00 USD | 812674.074% |
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 41.05 Thousand USD | -1503.296% |
| Medical Supply International USA, Inc. | 29.3 Thousand USD | -2145.982% |
| Polarean Imaging plc | 2.21 Million USD | 70.334% |
| Avitar, Inc. | 225.15 Thousand USD | -192.324% |
| AVITA Medical, Inc. | 3.12 Million USD | 78.914% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 136.22 Million USD | 99.517% |
| Zecotek Photonics Inc. | 94.9 Thousand USD | -593.556% |
| QHSLab, Inc. | 25.18 Thousand USD | -2513.816% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 136.22 Million USD | 99.517% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 11.15 Million USD | 94.102% |
| Escalon Medical Corp. | 1.61 Million USD | 59.198% |
| Aurora Spine Corporation | 3.54 Million USD | 81.429% |
| BrainsWay Ltd. | 3.71 Million USD | 82.293% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 14.36 Million USD | 95.419% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 414.75 Million USD | 99.841% |
| Kelyniam Global, Inc. | 46.22 Thousand USD | -1323.811% |
| REMSleep Holdings, Inc. | 99.14 Thousand USD | -563.848% |
| CYduct Diagnostics, Inc. | 12.19 Thousand USD | -5299.385% |
| Nanomix Corporation | - USD | -Infinity% |
| Theraclion SA | 3.05 Million EUR | 78.453% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 125.67 Thousand USD | -423.703% |
| Positron Corporation | 1.25 Million USD | 47.633% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 68.51 Thousand USD | -860.616% |
| Lombard Medical, Inc. | 6.87 Million USD | 90.429% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 157.55 Million USD | 99.582% |
| Vycor Medical, Inc. | 234.14 Thousand USD | -181.101% |
| Heart Tronics, Inc. | 163.85 Thousand USD | -301.685% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 128.99 Thousand USD | -410.225% |
| SANUWAVE Health, Inc. | 2.95 Million USD | 77.696% |
| VMS Rehab Systems, Inc. | 1.33 USD | -49487493.985% |
| Guided Therapeutics, Inc. | 632 Thousand USD | -4.143% |
| Ingen Technologies, Inc. | 85.59 Thousand USD | -668.962% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 313.4 Thousand USD | -110.008% |
| Urologix, Inc. | 1.39 Million USD | 52.886% |
| Rapid Therapeutic Science Laboratories, Inc. | 175.04 Thousand USD | -276.005% |
| Nexeon MedSystems Inc. | 2.2 Million USD | 70.172% |
| SS Innovations International, Inc. | 6.32 Million USD | 89.598% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.39 Billion USD | 99.972% |
| NIOX Group Plc | 6.11 Million USD | 89.228% |
| Fuse Medical, Inc. | 9.11 Million USD | 92.783% |
| Broncus Holding Corporation | 4.7 Million USD | 86.019% |
| Brain Scientific Inc. | 149.55 Thousand USD | -340.087% |
| Pressure BioSciences, Inc. | 304.9 Thousand USD | -115.863% |
| Health Logic Interactive Inc. | -4511.80 USD | 14688.08% |